MigraineMind research summary

Migraine prevalence, disease burden, and the need for preventive therapy

Neurology | 2007

Review
AuthorsLipton et al.
JournalNeurology
Publication year2007
PubMed ID17261680
DOI10.1212/01.wnl.0000252808.97649.21

Summary

Migraine is a common issue affecting many people in the United States. This study aimed to reassess migraine prevalence and treatment patterns among the population. Researchers mailed a validated headache questionnaire to 120,000 US households. They identified migraineurs using the International Classification of Headache Disorders criteria. The study included 162,576 individuals aged 12 years or older. The one-year prevalence of migraine was 12%. It was higher in women at 17% and lower in men at 6%. Prevalence peaked during middle age and decreased in adolescents and older adults. Among migraine patients, 31% experienced three or more attacks monthly. About 54% reported severe impairment requiring bed rest. Only 13% used daily preventive medication. The study found that more than 25% of migraineurs could benefit from preventive therapy. Many people who need these treatments are not receiving them. This highlights the need for better migraine management strategies. Clinical relevance: This research emphasizes the importance of preventive therapy for many migraine patients.

Key Learning Points

  • Migraine affects 12% of the US population, with higher rates in women and peak prevalence during middle age.
  • Many migraine sufferers experience significant impairment, with over half needing bed rest during attacks.
  • Only a small percentage of migraine patients, 13%, are using daily preventive medications despite their potential benefits.
  • More than a quarter of those with migraines could benefit from preventive therapy, indicating a treatment gap.
  • Improving migraine management strategies is essential to ensure that more patients receive appropriate care.

Related migraine research topics

Original research

Read the original publication and review its full methods and findings on PubMed.

MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.